Teva Drops Claim That Rival Slowed Generic Development
Teva Pharmaceuticals has voluntarily dropped its claims against Amicus Therapeutics Inc., which it had accused of hoarding supplies of a costly brand-name medication in violation of a new federal law aimed...To view the full article, register now.
Already a subscriber? Click here to view full article